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The carcinogenicity of chemicals, both
synthetic and naturally occurring, provides
a subject of intense personal interest to the
general public. The public debate on these
issues is frequently confused by the in-
accurate assessment of experimental or
epidemiological data by people with little
experience in this field. The Monographs
provide outstanding examples of reliable
opinions on experimental and epidemiological
studies in this difficult area.
I. F. H. PURCHASE
An Introduction to Cell Population
Kinetics. W. A. AHERNE, R. S. CAMPLEJOHN
and N. A. WRIGHT (1977) London: E. Arnold
Ltd. 88 pp. £2.95 net.
In view of the fact that there are other
established textbooks on cell kinetics, some
ofwhich these authors recommend for further
reading, one might question the need for yet
another book on the subject. However, this
short presentation does fill a gap in the cell-
kinetic literature in 2 valuable ways. It
provides firstly, a useful basis to the various
cell-kinetic techniques that are now ex-
tensively used, outlining their strengths and
weaknesses, and secondly, in a relatively
simple and clear fashion, some valuable
statistical considerations.
The book has been well written and edited
with few typographical errors. It is somewhat
expensive for an 80-page paperback (about
3.5p per text page). My one major criticism
was the quality of the 3 photomicrographs.
This, I'm sure, was partly the consequence of
the printing process, but their quality and
clarity did not reach the standards ofthe rest
of the text. Consequently the mitoses in
Plate 1 are difficult to identify (arrows would
have helped). Plate 3 was equally difficult
for the uninitiated reader; labelled cells
could be seen with difficulty, even ifone knew
what to look for. Since the preface clearly
indicates that the book is designed to intro-
duce the reader to the subject, I think it is
unfortunate that the plates were not better. I
also found it somewhat surprising that the
book omitted reference to the original 1953
cell-cycle paper of Howard and Pelc.
The authors point out in the preface that
this is not a recipe book, but I feel that brief
recipes of the major techniques would have
been helpful to the type ofreader at whom the
book is directed.
I found that I had personal misgivings
about some of the statements and interpreta-
tions, particularly when some techniques are
applied to highly organized tissues which are
much more complex in terms of their cellular
heterogeneity than any cell-culture system.
However, the general content of the book
was good, and it should prove to be a useful
asset to research laboratories, particularly for
those beginning to work in the field. I found
the summaries at the end ofeach section very
helpful.
C. S. POTTEN
Immunocancerology in Solid Tumors Ed.
M. MARTIN and L. DIONNE (1976) New York:
Stratton Intercontinental Medical Book Corp.
182 pp. U.S.$17.95 net.
Thismonograph constitutes theproceedings
ofa Symposiumheld intheMedical Faculty of
of the University of Laval, Quebec, Canada.
The amount of new information disclosed is
of modest proportions, and the approach is
distinctly pro-clinical, and in many respects,
superficial.
A somewhat ambiguous tone is set by 2 of
the introductory articles. The first, by R. B.
Herberman, is a characteristically incisive
approach to the problem of human tumour
immunogenicity, in which the point is well
made that, even in animal model systems,
there is considerable complexity in the
debatable immune responses, and it is not at
all clear which ofthe antigens and correspond-
ing host reactions are really relevant in vivo.
The second, by G. M. Mavligit, still under the
heading of'Fundamental Concepts", is a more
opportunist approach, in which immunity to
human tumours is uncritically assumed and
its therapeutic exploitation almost a foregone
conclusion. However, this "fundamental" is
subsequently seen to be far from secure, and
whilst several tests are reported to be potenti-
ally useful in the "Immunological Work-up"
of the cancer patient, including leucocyte-
adherenceinhibition, migration inhibition and
CEA assays, few data are presented to indi-
catetheir actualusefulness in clinical practice.
Possibly, as Herberman again points out, such
assays mayultimately be ofvalue in combina-
tions, ifnot alone, in the monitoring or initial
diagnosis ofmalignant disease. Even so there